Kühl et al. (23) highlighted the significance of IL-4 as a crucial cytokine in breast cancer survivors due to its immunoregulatory actions and indirect impact on the tumor microenvironment, closely associated with the occurrence and progression of CRF. This evidence concerns the gene IL4 and neoplasm.